TriNetX

Cambridge, MA, United States  All United States companies → Founded 2013
Biotech / Drug Discovery Clinical AI Platform Healthcare Analytics / BI
Acquired (by The Carlyle Group in 2020), with recent investments — $302M

Products

TriNetX Live™
TriNetX
Drug Discovery & Research
TriNetX Live™ is a global real-world data platform that leverages AI and human intelligence to help healthcare organizations and researchers design clinical trials, identify patient cohorts, and generate real-world evidence.

See all 1 product →

About TriNetX

TriNetX operates a global health research network that connects healthcare organizations, biopharmaceutical companies, and contract research organizations (CROs), leveraging artificial intelligence and machine learning to enhance its platform. For physicians, this platform provides real-time access to a vast, de-identified repository of longitudinal clinical data derived from electronic health records (EHRs), encompassing over 275 million patients across more than 170 healthcare organizations in over 30 countries. The data is harmonized to standard terminologies like ICD-10 and LOINC, making it readily usable for research without extensive data wrangling. This capability allows physicians to explore patient populations, investigate attributes and comorbidities of specific cohorts, and rigorously analyze inclusion/exclusion criteria to determine the feasibility of clinical studies.

The TriNetX platform empowers physicians to optimize clinical trial design, streamline site selection, and accelerate patient recruitment, significantly reducing the time required for site identification. Beyond trial operations, it facilitates the generation of real-world evidence (RWE) for observational studies, comparative safety and effectiveness research, and pharmacovigilance efforts. The system can extract clinical facts from both structured EMR data and unstructured physician notes and clinical reports using natural language processing (NLP), providing a more comprehensive view of patient data. This robust data environment supports a data-driven approach to understanding disease trends, treatment patterns, and patient outcomes, ultimately aiming to advance medical discoveries and bring new therapies to market faster for improved patient care.

Furthermore, TriNetX fosters collaboration among researchers from life sciences, academic medical centers, and community providers globally. Physicians can participate in multi-site research initiatives, pursue grant-based funding, and strengthen relationships with pharmaceutical companies and other healthcare organizations. The platform’s consulting services also offer expert guidance in real-world data and evidence generation, protocol design, feasibility, and site selection, providing tailored support for complex clinical questions.

Focus Areas

Clinical Trial Design & Optimization Real-World Evidence Generation Patient Cohort Identification Data Analytics Pharmacovigilance & Drug Safety Genomics Data Federation AI/Machine Learning in Clinical Research Site Selection Patient Recruitment Outcomes Analysis

Business Intelligence

Key InvestorsMerck Global Health Innovation Fund, Mitsui & Co., Ltd., ITOCHU Technology Ventures, ITOCHU Corporation, MPM Capital, F2 Ventures, Deerfield Management, The Carlyle Group (Acquirer)
PartnershipsRegeneron (April 2026), Fujitsu (February 2025)
AcquisitionsZetta Genomics (April 2026), Advera Health Analytics (January 2022), OncologyInformationService and CancerDataNet (October 2022), InSite, Custodix
TechnologyTriNetX LIVE™ platform, federated health data network, real-world data (RWD) and real-world evidence (RWE) ecosystem, AI and machine learning capabilities, natural language processing (NLP) for unstructured data, cloud-based system

What Physicians Need to Know

Clinical Trial Design & Optimization
TriNetX leverages real-world data (RWD) and AI to refine clinical trial protocols, significantly reducing protocol amendments by up to 50% and accelerating development timelines. It offers tools for data-driven trial design, ensuring studies are more efficient and tailored.
Real-World Evidence Generation
As the most cited real-world data source in peer-reviewed research, TriNetX provides a vast federated network of de-identified electronic health records (EHRs) and claims data. This enables robust real-world evidence (RWE) generation, crucial for regulatory decisions, comparative effectiveness, and health economics and outcomes research (HEOR).
Patient Cohort Identification
The platform offers real-time access to a global federated network of nearly 300 million de-identified patient records, allowing researchers to instantly query and identify specific patient cohorts based on demographics, diagnoses, procedures, medications, labs, and genomics. This streamlines study feasibility and supports diverse populations.
Data Analytics
TriNetX provides a state-of-the-art analytics suite for deep insights into patient populations, cohort comparisons, treatment pathways, incidence, and prevalence. It includes statistically robust tools like propensity score matching (PSM) to reduce confounders in retrospective studies and enhance the accuracy of causal inference.
Pharmacovigilance & Drug Safety
TriNetX aids in refining safety signals and enhancing drug safety monitoring by providing access to harmonized global pharmacovigilance (PV) data. This allows for faster and more reliable detection of adverse drug reactions, supporting clinical decision-making.
Genomics Data Federation
Through the acquisition of Zetta Genomics and its XetaBase platform, TriNetX has expanded its capabilities to securely federate and analyze multiomic data alongside phenotypic data. This enables advanced pharmacogenomic and personalized medicine studies.
AI/Machine Learning in Clinical Research
TriNetX integrates AI and ML models to optimize various aspects of clinical research, including protocol design, site identification (achieving a 63% site acceptance rate), patient recruitment (reducing enrollment time by up to 40%), and ensuring trial diversity.
Site Selection
The platform revolutionizes site selection with a patient-centric approach, using RWD to identify sites where target populations already receive treatment. Integration with DrugDev Golden Number standardizes site identification, leading to higher patient match rates and improved site engagement.
Patient Recruitment
TriNetX accelerates patient recruitment through digital waiting rooms and AI-powered tools that identify eligible patients in real-time. This approach helps overcome recruitment barriers, improves patient retention, and ensures diverse and representative patient populations for trials.
Outcomes Analysis
TriNetX supports comprehensive outcomes analysis, allowing researchers to study disease progression, treatment efficacy, and long-term toxicities. It facilitates retrospective cohort studies, survival analysis, and the use of propensity score matching for robust and accurate results.
Physician Tip

For physicians, TriNetX offers a powerful avenue to enhance patient care and contribute to medical advancements. By partnering with healthcare organizations utilizing TriNetX, you can: nn* **Accelerate Patient Access to Trials:** Quickly identify eligible patients for clinical trials, offering them opportunities for cutting-edge treatments and improving enrollment timelines.n* **Inform Clinical Decisions with RWE:** Gain insights into real-world treatment patterns and outcomes from a vast patient population, complementing traditional trial data and informing your clinical decision-making.n* **Reduce Administrative Burden:** Streamline the process of identifying potential trial participants, freeing up time for direct patient care.n* **Contribute to Diverse Research:** Facilitate the inclusion of underrepresented patient populations in studies, ensuring that research findings are more broadly applicable and equitable.n* **Engage in Collaborative Research:** Leverage the global federated network to collaborate on research, explore hypotheses, and publish findings, advancing medical knowledge.n* **Ensure Patient Privacy:** Be confident that patient data is de-identified and handled with robust security measures, complying with regulations like HIPAA and GDPR.

TriNetX's platform is built on a cloud-based infrastructure, notably leveraging Databricks for advanced analytics and machine learning capabilities. It integrates with industry standards like FHIR for genomic data and incorporates tools such as DrugDev Golden Number for standardized site identification. The platform's federated architecture allows for seamless, privacy-compliant data access across diverse healthcare systems, and it is continuously exploring further AI integration for new RWD use cases.

Products by TriNetX

1 product in the directory

TriNetX Live™
TriNetX
Drug Discovery & Research
TriNetX Live™ is a global real-world data platform that leverages AI and human intelligence to help healthcare organizations and researchers design clinical trials, identify patient cohorts, and generate real-world evidence.

What the Web Says

TriNetX is a global health research network that provides real-time access to longitudinal clinical data and analytics for optimizing clinical research and generating real-world evidence. It is highly regarded as a valuable resource for healthcare research, particularly for large-scale observational studies, rare disease studies, post-market surveillance, and comparative effectiveness research. However, some concerns exist regarding the potential for misleading studies if used by inexperienced researchers without proper mentorship, due to biases inherent in retrospective data and issues with EHR coding accuracy. As an employer, TriNet (the HR solutions company, distinct from TriNetX) receives mixed reviews, with some praising its comprehensive HR platform and benefits, while others criticize its customer support, high fees, and recent changes in company culture.

Overall: Mixed

Strengths

  • Real-time access to extensive real-world clinical data.
  • Advanced analytics and machine learning tools for research.
  • Valuable for various research types, including rare diseases and post-market surveillance.
  • Streamlines HR, payroll, and benefits administration (for TriNet HR platform).
  • Offers comprehensive benefits options (for TriNet HR platform).
  • User-friendly interface and intuitive design (for TriNet HR platform).

Limitations

  • Potential for biases (selection bias, confounding variables) due to reliance on retrospective data.
  • Data reliability can be affected by electronic health record coding accuracy.
  • Limited demographic representation in data may affect generalizability of results.
  • Concerns about inexperienced users producing misleading research without mentorship.
  • Poor customer support and unhelpful agents (for TriNet HR platform).
  • High fees and lack of transparency (for TriNet HR platform).

Based on reviews from: FeaturedCustomers, ASIDE Internal Medicine, PMC, PubMed, G2, Reddit, Capterra, Indeed.com

Last updated: 2026-08-21

Videos

News, demos, and interviews about TriNetX.

Loading videos...

Videos load interactively. If none appear, search YouTube for TriNetX →

View all on YouTube

Press & Coverage

TriNetX Press Release
TriNetX Appoints August Calhoun Chief Executive Officer
TriNetX, a global federated health data network, announced the appointment of August Calhoun as its new Chief Executive Officer, effective immediately.
2026-07
TriNetX Press Release
TriNetX Supports European Healthcare Organizations on the Path to EHDS Readiness
TriNetX launched an initiative to help European healthcare organizations transform and harmonize their clinical data to align with European Health Data Space (EHDS) requirements, supporting interoperability and compliance.
2026-08
TriNetX Press Release
TriNetX LIVEu2122 Network Surpasses 300 Million Patients, Expanding Decision-Grade Evidence Across Global Healthcare
TriNetX announced that its TriNetX LIVEu2122 network now includes over 300 million patients, providing a single, federated source of real-world data for pharmaceutical companies, researchers, and healthcare innovators.
2026-06
PR Newswire
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
TriNetX and Regeneron Pharmaceuticals announced a strategic collaboration to provide Regeneron with access to TriNetX's network of approximately 300 million de-identified patient records to advance drug discovery and digital health solutions.
2026-04
TriNetX Press Release
TriNetX Unveils Conversational AI Interface and Enhanced API Capabilities
TriNetX announced new AI capabilities, including a conversational AI interface, to make sophisticated clinical research analytics more accessible by allowing researchers to query its global network using natural language.
2026-01
TriNetX Blog
Proof in Publications u2013 The Most Cited. The Most Trusted. TriNetX Real-World Data
As of July 2026, over 4,000 peer-reviewed publications have used or cited TriNetX data, with a record 738 publications appearing in Q2 2026, highlighting its growing reliance in global research.
2026-08
Frontiers in Pharmacology
A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX
This article reviews the methodologies and applications of the TriNetX platform, noting a dramatic increase in publications using the network, with close to 1,000 as of September 2024, including in high-ranking journals.
2024-09
MDPI (Journal of Clinical Medicine)
Mapping TriNetX-Based Real-World Evidence Publications by Clinical Domain and Study Purpose, 2018u20132025: A Bibliometric Analysis
A bibliometric analysis of TriNetX-based research from 2018 to 2025 shows a rapid expansion in its use for real-world evidence generation across diverse clinical domains, with annual output increasing significantly.
2026-07
No FAQs available yet for this company.

Investors

Who's funded TriNetX.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.